Search Results - "HOLLIS, R. J"

Refine Results
  1. 1

    In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance by Pfaller, M.A, Boyken, L, Hollis, R.J, Kroeger, J, Messer, S.A, Tendolkar, S, Diekema, D.J

    Published in Journal of Clinical Microbiology (01-01-2008)
    “…The echinocandins are being used increasingly as therapy for invasive candidiasis. Prospective sentinel surveillance for the emergence of in vitro resistance…”
    Get full text
    Journal Article
  2. 2

    Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp by Pfaller, M.A, Boyken, L, Hollis, R.J, Kroeger, J, Messer, S.A, Tendolkar, S, Jones, R.N, Turnidge, J, Diekema, D.J

    Published in Journal of Clinical Microbiology (01-01-2010)
    “…We tested a global collection of Candida sp. strains against anidulafungin, caspofungin, and micafungin, using CLSI M27-A3 broth microdilution (BMD) methods,…”
    Get full text
    Journal Article
  3. 3

    Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi by DIEKEMA, D. J, MESSER, S. A, HOLLIS, R. J, JONES, R. N, PFALLER, M. A

    Published in Journal of Clinical Microbiology (01-08-2003)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4

    In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods by DIEKEMA, D. J, MESSER, S. A, BOYKEN, L. B, HOLLIS, R. J, KROEGER, J, TENDOLKAR, S, PFALLER, M. A

    Published in Journal of Clinical Microbiology (01-10-2009)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  5. 5

    In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance by Pfaller, M. A, Boyken, L, Hollis, R. J, Messer, S. A, Tendolkar, S, Diekema, D. J

    Published in Journal of Clinical Microbiology (01-03-2006)
    “…Caspofungin is being used increasingly as therapy for invasive candidiasis. Prospective sentinel surveillance for emergence of in vitro resistance to…”
    Get full text
    Journal Article
  6. 6

    Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007 by Pfaller, M.A, Messer, S.A, Hollis, R.J, Boyken, L, Tendolkar, S, Kroeger, J, Diekema, D.J

    Published in Journal of Clinical Microbiology (01-10-2009)
    “…We examined the susceptibilities to fluconazole of 642 bloodstream infection (BSI) isolates of Candida glabrata and grouped the isolates by patient age and…”
    Get full text
    Journal Article
  7. 7

    In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to Fluconazole by Pfaller, M. A, Boyken, L, Hollis, R. J, Messer, S. A, Tendolkar, S, Diekema, D. J

    Published in Journal of Clinical Microbiology (01-11-2005)
    “…Anidulafungin is an echinocandin antifungal agent with potent activity against Candida spp. We assessed the in vitro activity of anidulafungin against 2,235…”
    Get full text
    Journal Article
  8. 8

    In Vitro Susceptibility of Clinical Isolates of Aspergillus spp. to Anidulafungin, Caspofungin, and Micafungin: a Head-to-Head Comparison Using the CLSI M38-A2 Broth Microdilution Method by Pfaller, M.A, Boyken, L, Hollis, R.J, Kroeger, J, Messer, S.A, Tendolkar, S, Diekema, D.J

    Published in Journal of Clinical Microbiology (01-10-2009)
    “…We determined the in vitro activities of anidulafungin, caspofungin, and micafungin against 526 isolates of Aspergillus spp. (64 A. flavus, 391 A. fumigatus,…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Global Trends in the Antifungal Susceptibility of Cryptococcus neoformans (1990 to 2004) by PFALLER, M. A, MESSER, S. A, BOYKEN, L, RICE, C, TENDOLKAR, S, HOLLIS, R. J, DOERN, G. V, DIEKEMA, D. J

    Published in Journal of Clinical Microbiology (01-05-2005)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  11. 11

    In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species by Pfaller, M.A, Messer, S.A, Boyken, L, Rice, C, Tendolkar, S, Hollis, R.J, Diekema, D.J

    Published in Journal of Clinical Microbiology (01-08-2008)
    “…Few data exist to describe in vitro patterns of cross-resistance among large collections of clinical Aspergillus isolates, including those of species other…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000 by PFALLER, M. A, DIEKEMA, D. J, JONES, R. N, MESSER, S. A, HOLLIS, R. J

    Published in Journal of Clinical Microbiology (01-03-2002)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution by Pfaller, M.A, Boyken, L, Hollis, R.J, Kroeger, J, Messer, S.A, Tendolkar, S, Diekema, D.J

    Published in Journal of Clinical Microbiology (01-02-2011)
    “…We tested 16,191 strains of Candida against posaconazole and voriconazole, using the CLSI M27-A3 broth microdilution (BMD) method (24-h incubation), in order…”
    Get full text
    Journal Article
  16. 16
  17. 17

    In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp by PFALLER, M. A, MESSER, S. A, HOLLIS, R. J, JONES, R. N, DIEKEMA, D. J

    Published in Antimicrobial Agents and Chemotherapy (01-06-2002)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998 by PFALLER, M. A, JONES, R. N, DOERN, G. V, SADER, H. S, MESSER, S. A, HOUSTON, A, COFFMAN, S, HOLLIS, R. J

    Published in Antimicrobial Agents and Chemotherapy (01-03-2000)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  20. 20

    Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida spp by Messer, S. A, Diekema, D. J, Boyken, L, Tendolkar, S, Hollis, R. J, Pfaller, M. A

    Published in Journal of Clinical Microbiology (01-02-2006)
    “…Micafungin is a new echinocandin exhibiting broad-spectrum activity against Candida spp. The activity of the echinocandins against Candida species known to…”
    Get full text
    Journal Article